Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David T Curiel

Showing results (71-80 of 400) with videos related to

Pageof 40
Sort By:
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 6, 2006
Adenovirus-mediated p53 tumor suppressor gene therapy of osteosarcomaVladimir V Ternovoi, David T Curiel, Bruce F Smith, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 19, 2004
Adenovirus-mediated gene delivery to dendritic cellsLaura Timares, Joanne T Douglas, Bryan W Tillman, et al.
Virology|July 6, 2005
Genetic incorporation of HSV-1 thymidine kinase into the adenovirus protein IX for functional display on the virionJing Li, Long Le, Don A Sibley, et al.
Journal of Virology|November 20, 2002
Construction and characterization of adenovirus serotype 5 packaged by serotype 3 hexonHongju Wu, Igor Dmitriev, Elena Kashentseva, et al.
Molecular Cancer Therapeutics|March 21, 2006
Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenovirusesSvetlana Komarova, Yosuke Kawakami, Mariam A Stoff-Khalili, et al.
Journal of Molecular Biology|January 9, 2007
Thermostability/infectivity defect caused by deletion of the core protein V gene in human adenovirus type 5 is rescued by thermo-selectable mutations in the core protein X precursorHideyo Ugai, Anton V Borovjagin, Long P Le, et al.
Molecular Therapy Oncolytics|April 28, 2016
Retargeted oncolytic adenovirus displaying a single variable domain of camelid heavy-chain-only antibody in a fiber proteinElisabeth A van Erp, Lyudmila N Kaliberova, Sergey A Kaliberov, et al.
Cancer Research|August 17, 2002
Novel oncolytic adenoviruses targeted to melanoma: specific viral replication and cytolysis by expression of E1A mutants from the tyrosinase enhancer/promoterDirk M Nettelbeck, Angel A Rivera, Cristina Balagué, et al.
Virus Research|August 22, 2006
Members of adenovirus species B utilize CD80 and CD86 as cellular attachment receptorsJoshua J Short, Chenthamarakshan Vasu, Mark J Holterman, et al.
Cancer Research|January 17, 2009
Combined transductional untargeting/retargeting and transcriptional restriction enhances adenovirus gene targeting and therapy for hepatic colorectal cancer tumorsHua-Jung Li, Maaike Everts, Masato Yamamoto, et al.
Pageof 40

Showing results (71-80 of 400) with videos related to

Sort By:
Pageof 40
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 6, 2006
Adenovirus-mediated p53 tumor suppressor gene therapy of osteosarcomaVladimir V Ternovoi, David T Curiel, Bruce F Smith, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 19, 2004
Adenovirus-mediated gene delivery to dendritic cellsLaura Timares, Joanne T Douglas, Bryan W Tillman, et al.
Virology|July 6, 2005
Genetic incorporation of HSV-1 thymidine kinase into the adenovirus protein IX for functional display on the virionJing Li, Long Le, Don A Sibley, et al.
Journal of Virology|November 20, 2002
Construction and characterization of adenovirus serotype 5 packaged by serotype 3 hexonHongju Wu, Igor Dmitriev, Elena Kashentseva, et al.
Molecular Cancer Therapeutics|March 21, 2006
Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenovirusesSvetlana Komarova, Yosuke Kawakami, Mariam A Stoff-Khalili, et al.
Journal of Molecular Biology|January 9, 2007
Thermostability/infectivity defect caused by deletion of the core protein V gene in human adenovirus type 5 is rescued by thermo-selectable mutations in the core protein X precursorHideyo Ugai, Anton V Borovjagin, Long P Le, et al.
Molecular Therapy Oncolytics|April 28, 2016
Retargeted oncolytic adenovirus displaying a single variable domain of camelid heavy-chain-only antibody in a fiber proteinElisabeth A van Erp, Lyudmila N Kaliberova, Sergey A Kaliberov, et al.
Cancer Research|August 17, 2002
Novel oncolytic adenoviruses targeted to melanoma: specific viral replication and cytolysis by expression of E1A mutants from the tyrosinase enhancer/promoterDirk M Nettelbeck, Angel A Rivera, Cristina Balagué, et al.
Virus Research|August 22, 2006
Members of adenovirus species B utilize CD80 and CD86 as cellular attachment receptorsJoshua J Short, Chenthamarakshan Vasu, Mark J Holterman, et al.
Cancer Research|January 17, 2009
Combined transductional untargeting/retargeting and transcriptional restriction enhances adenovirus gene targeting and therapy for hepatic colorectal cancer tumorsHua-Jung Li, Maaike Everts, Masato Yamamoto, et al.
Pageof 40